You are here

Article info

Article menu

Download PDFPDF

Clinical/translational cancer immunotherapy
Original research
Complex immune microenvironment of chordoma: a road map for future treatment

Authors

  • Hua-Qing Niu Department of Ophthalmology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Bo-Yv Zheng Department of Orthopedics Surgery, General Hospital of the Central Theater Command, Wuhan, China PubMed articlesGoogle scholar articles
  • Ming-Xiang Zou Department of Spine Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China PubMed articlesGoogle scholar articles
  • Bo-Wen Zheng Department of Spine Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, ChinaMusculoskeletal Tumor Center, Peking University People's Hospital, Peking University, Beijing, China PubMed articlesGoogle scholar articles

Citation

Niu H, Zheng B, Zou M, et al
Complex immune microenvironment of chordoma: a road map for future treatment
Journal for ImmunoTherapy of Cancer 2024;12:e009313. doi: 10.1136/jitc-2024-009313
Online issue publication 
June 21, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.